Beneficial effect of interferon-beta 1b treatment in patients with relapsing-remitting multiple sclerosis is associated with an increase in serum levels of soluble HLA-I molecules during the first 3 months of therapy.
J Neuroimmunol
; 148(1-2): 206-11, 2004 Mar.
Article
en En
| MEDLINE
| ID: mdl-14975603
Buscar en Google
Colección:
01-internacional
Asunto principal:
Interferón beta
/
Esclerosis Múltiple Recurrente-Remitente
/
Antígenos HLA
Tipo de estudio:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
J Neuroimmunol
Año:
2004
Tipo del documento:
Article
País de afiliación:
Italia